Friederike Schneider

Author

Also Known As

Annika Dufour, F Schneider, F. J. Schneider, F. Schneider, F.-J. Schneider, Friederike Schneider, Schneider, Frederike, Schneider, Friederike

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

University of Münster German Society of Surgery Helmholtz Zentrum München Munich Leukemia Laboratory (Germany)Universität Ulm

About

Friederike Schneider is an author at University of Münster specializing in medicine, pathology, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	134
2	Pathology	2	2	91
3	Allergy	1	1	43
4	Immunology	1	1	11
5	Pharmacology	1	1	43

Friederike Schneider

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Acute Myeloid Leukemia With Biallelic <i>CEBPA</i> Gene Mutations and Normal Karyotype Represents a Distinct Genetic Entity Associated With a Favorable Clinical Outcome Annika Dufour, Friederike Schneider, Klaus H. Metzeler, Journal of Clinical Oncology	2009	292
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma Claudia Lengerke, Tanja Fehm, Ralf Kurth, BMC Cancer	2011	190
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia Philipp A. Greif, Annika Dufour, Nikola P. Konstandin, Blood	2012	147
RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes Philipp A. Greif, Nikola P. Konstandin, Klaus H. Metzeler, Haematologica	2012	98
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML) Friederike Schneider, Eva Hoster, Stephanie Schneider, Annals of Hematology Age-dependent FrequenciesGenetic DisorderMedicineGeneticsNormal Karyotype Aml	2011	80
Rapid and sensitive screening for <i>CEBPA</i> mutations in acute myeloid leukaemia Tobias Benthaus, Friederike Schneider, Gudrun Mellert, British Journal of Haematology	2008	69
NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS) Friederike Schneider, Eva Hoster, Michael Unterhalt, Blood	2009	58
The FLT3ITD mRNA level has a high prognostic impact in NPM1 mutated, but not in NPM1 unmutated, AML with a normal karyotype Friederike Schneider, Eva Hoster, Michael Unterhalt, Blood	2012	48
Effect of Anti-Inflammatory Agents on Acute Experimental Synovitis In Dogs Marvin E. Rosenthale, Jacob Kassarich, Friederike Schneider Experimental Biology and Medicine Veterinary ResearchUnanes-thetized DogsInflammatory ArthritisInflammationRheumatoid Disorder	1966	43
Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease Judith Weber, Valerie Glutsch, Eva Geissinger, British Journal of Dermatology	2019	27

Page 1